Hervé Brailly, CEO, is invited to the panel discussion "French Public Markets – Breakthrough Technologies Panel".
Zurich,Switzerland
More info
Dr. Squiban, 53, joined Innate Pharma after eight years at Transgene (1997-2005), a French company dedicated to the discovery and development of therapeutic vaccines and gene therapy products, as Director of Medical Affairs Europe and then as Vice President, Medical and Regulatory Affairs.
| Download Area |
|---|
| PR in english |